Topic: European Medicines Agency
Sibutramine , usually available as sibutramine hydrochloride monohydrate, is an orally administered agent for the treatment of obesity , as an appetite suppressant . It is also under review by the FDA and the European Medicines Agency . In 2010 the FDA ...